Iron overload damages mitochondria and induces metabolic rewiring of hematopoietic stem cells toward glycolysis

S Silvia Sighinolfi (1San Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy) L Laura Cassina (2Division of Genetics and Cell Biology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy) M Maria Rosa Lidonnici S Stefano Beretta D Davide Stefanoni (2Division of Genetics and Cell Biology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy) M Mariangela Storto C Christina Mayerhofer (3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA) T Trine A. Kristiansen (3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA) D David T. Scadden (3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA) I Ivan Merelli A Alessandra Boletta (2Division of Genetics and Cell Biology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy) A Annamaria Aprile G Giuliana Ferrari

Abstract

Abstract Iron is an essential element for most cellular processes, and recent evidence highlighted its role in regulating the function of hematopoietic stem cells (HSCs). Abnormal iron levels affect HSC quiescence and self-renewal; however, the mechanism by which iron overload (IO) influences HSC function is still unknown. Here, we show that intracellular IO impairs mitochondrial fitness and bioenergetics, inducing metabolic rewiring. In thalassemic mice, as a model of chronic IO, HSCs accumulate elevated mitochondrial reactive oxygen species (mtROS), low mitochondrial membrane potential, and reduced oxidative phosphorylation. Mitochondrial defects are confirmed in 2 other models of IO, sickle cell disease and iron-loaded wild-type mice, and in vivo iron reduction rescues HSC mitochondria. IO HSCs are highly proliferating and, in the presence of damaged mitochondria, rely on glycolysis for energy production. Notably, restoration of mitochondrial function by targeting in vivo mtROS improved the quiescence and self-renewal of IO HSCs. Our results unravel the critical interplay between iron, ROS, and mitochondrial activity in HSCs, revealing that IO shapes HSC metabolic programs.

Article Details

Journal Blood
Volume / Issue Vol. 147, Issue 26
Published June 25, 2026
Pages 3217-3230
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (13)

S

Silvia Sighinolfi

1San Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy

L

Laura Cassina

2Division of Genetics and Cell Biology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy

M

Maria Rosa Lidonnici

S

Stefano Beretta

D

Davide Stefanoni

2Division of Genetics and Cell Biology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy

M

Mariangela Storto

C

Christina Mayerhofer

3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA

T

Trine A. Kristiansen

3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA

D

David T. Scadden

3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA

I

Ivan Merelli

A

Alessandra Boletta

2Division of Genetics and Cell Biology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy

A

Annamaria Aprile

G

Giuliana Ferrari